News

Find News

Filter articles

Showing 61 to 70 of 2948 results

EMA unveils fast-track drug shortage monitoring

EU08-04-2020Rory O'Neill

The EU’s drugs regulator has set up a fast-track system to monitor shortages during the COVID-19 pandemic.

EU should buy patent rights for COVID-19 tests, says Greece

Greece07-04-2020Sarah Morgan

Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.  

Shkreli wants Thiola antitrust claims thrown out

06-04-2020

Notorious ‘pharma bro’ Martin Shkreli and his former drug company Retrophin want antitrust claims filed against them in federal court dismissed.

Mewburn expands UK IP team

06-04-2020

Mewburn Ellis has appointed a new life sciences-focused partner as part of a number of promotions in its IP team.

BIO moves 2020 international convention online

US06-04-2020Sarah Morgan

The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.

UK man charged with smuggling mislabelled COVID-19 kits into US

UK, US03-04-2020Sarah Morgan

A British man has been charged with smuggling mislabelled drugs, purporting to be a treatment for those suffering from COVID-19, into the US. 

Sanofi announces new vaccine project as Australia begins animal tests

Australia, France, US02-04-2020

France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.

Gilead fails to overturn $752m BMS patent verdict

US02-04-2020Sarah Morgan

A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies. 

EIP boosts life sciences practice with Mathys & Squire partner

UK02-04-2020

IP law firm EIP has enhanced its life science capabilities with the addition of Monika Rai as a partner. 

Gilead told to waive remdesivir patent rights

International02-04-2020Rory O'Neill

Almost 150 health and poverty activist campaigns, including Médecins Sans Frontières, have urged Gilead Sciences to waive patent and exclusivity rights for potential COVID-19 treatment remdesivir.

Showing 61 to 70 of 2948 results

LSIPR